Nabpac 100mg Injection
Marketer
RPG Life Sciences Ltd
Salt Composition
Paclitaxel (100mg)
Overview Nabpac 100mg Injection
Oncaspar (100mg injection) is an anticancer drug indicated for breast, pancreatic, and non-small cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent immediately; discontinue only under medical guidance. Common side effects include nausea, vomiting, and fatigue. Serious side effects, such as edema, alopecia, and weight increase, are possible. Concomitant medications may mitigate these. Report unusual bruising or bleeding, sore throat, mouth sores, or fever to your physician. This medication may suppress blood cell counts, increasing infection risk. Regular blood tests monitoring blood cell levels and liver function are essential. Inform your doctor of any pre-existing heart, liver, or kidney conditions, and all other medications, particularly those for infections, before commencing treatment. Interactions with other drugs are possible; comprehensive medication disclosure is crucial. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is necessary throughout treatment.
Primary Ingredients of Nabpac 100mg Injection
No text provided to rephrase.
Uses of Nabpac 100mg Injection
Cancers of the breast, lung (non-small cell), and pancreas
Major Benefits of Nabpac 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nabpac 100mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Nabpac 100mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Nabpac 100mg Injection works:
Oncaspar 100mg Injection is a chemotherapeutic agent. Its mechanism of action involves disrupting microtubule networks, essential for cancerous cell proliferation. This inhibits tumor growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Nabpac 100mg Injection should not be taken together.
PregnancyCONSULT YOUR DOCTOR
Using Nabpac 100mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Administering Nabpac 100mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant harm due to the medication's toxicity.
DrivingUNSAFE
The injectable medication Nabpac 100mg might produce adverse reactions that could impair driving ability. While driving isn't necessarily prohibited between Nabpac 100mg Injection treatments, it's important to note the presence of alcohol in this medicine and consider the potential risks to safe driving.
KidneySAFE IF PRESCRIBED
Nabpac 100mg Injection poses no known safety risk for patients with renal impairment, and no dosage modification is advised. Nevertheless, consult your physician regarding your kidney health before using this medication.
LiverCAUTION
Individuals with liver impairment should use Nabpac 100mg Injection cautiously, potentially requiring a modified dosage. Medical advice is essential. The injection is contraindicated for patients exhibiting severe hepatic dysfunction.
What if you forget to take Nabpac 100mg Injection :
NA
Facts to Know About Nabpac 100mg Injection
| Label | Value |
|---|---|
| Chemical Category | Taxane-based Drugs |
| Developing Habits | No. |
| Type of Therapy | Cancer Therapeutics |
| Behavioral Class | Taxanes: Antimicrotubule Agents |
3,018 People bought this recently